Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

Lori Murray

Home/Tag:Lori Murray
10 10, 2010

More About Delay Of The New Drug Application (NDA) Filing For Carfilzomib Thursday

Tags: , , , , , |0 Comments

Yesterday I reported that Onyx Pharmaceuticals had temporarily delayed their drug application with the FDA for the new and highly anticipated anti-myeloma drug, carfilzomib.In the article, I passed along an e-mail I received from the company's Director of Corporate Communications & Investor Relations, Lori Murray.I was able to reach Lori by phone later in the

27 09, 2010

Follow-Up To Reader From India’s Question About Carfilzomib Studies

Tags: , , |0 Comments

I just heard back from Onyx Pharmaceuticals' Director of Communications, Lori Murray, with an answer to yesterday's question from our reader in India:Hi Pat, We have a Phase 3 trial in Europe/Eastern Europe evaluating CFZ in relapsed/refractory to support a European filing. Unfortunately, we don’t have anything currently enrolling in India in the relapsed/refractory setting.

13 06, 2010

Thoughts About My Interview With Onyx Pharmaceuticals’ Chief Medical Officer, Dr. Michael Kauffman At ASCO

Tags: , , , , , , , |0 Comments

I started an article about carfilzomib last Tuesday this way:  The Truth About The New Multiple Myeloma Novel Therapy Drug, Carfilzomib:"Is Onyx Pharmaceuticals' new, next generation proteasome inhibitor a new miracle drug—or just another “bit player” on the multiple myeloma scene? It depends who you ask."Well, you just read my interview with Dr. Michael Kauffman,

11 06, 2010

Interview With Onyx Pharmaceuticals’ Chief Medical Officer, Michael Kauffman- Part One

Tags: , , , , , |4 Comments

As promised, here is Part One of my three part series about last Friday's interview with Dr. Michael Kauffman, Chief Medical Officer/for Onyx Pharmaceuticals, maker of the new proteasome inhibitor, carfilzomib.First, here is what Google has to say about Dr. Kauffman:Director, CombinatoRx, Inc. CMO, Onyx PharmaceuticalsBoston , MA Sector: HEALTHCARE / Biotechnology 46 Years Old